Analysis of Gene Expression Identifies Differentially Expressed Genes and Pathways Associated with Lymphatic Dissemination in Patients with Adenocarcinoma of the Esophagus

[1]  Ju-Han Lee,et al.  Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase , 2007, International journal of cancer.

[2]  K. Becker,et al.  A rapid method for microarray cross platform comparisons using gene expression signatures. , 2007, Molecular and cellular probes.

[3]  Y. Leung,et al.  Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. , 2007, Cancer research.

[4]  D. Richel,et al.  Molecular Prognostic Factors in Adenocarcinoma of the Esophagus and Gastroesophageal Junction , 2007, Annals of Surgical Oncology.

[5]  F. Holstege,et al.  Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis. , 2006, Cancer research.

[6]  Roland Eils,et al.  Group testing for pathway analysis improves comparability of different microarray datasets , 2006, Bioinform..

[7]  J. Reitsma,et al.  Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Cerfolio,et al.  Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival. , 2006, The Annals of thoracic surgery.

[9]  T. Lerut,et al.  Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction , 2006, Current Opinion in Gastroenterology.

[10]  P. Fockens,et al.  Stepwise Radical Endoscopic Resection Is Effective for Complete Removal of Barrett's Esophagus with Early Neoplasia: A Prospective Study , 2006, The American Journal of Gastroenterology.

[11]  B. Têtu,et al.  Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors. , 2006, International journal of oncology.

[12]  E. Kuipers,et al.  Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers. , 2006, Gastrointestinal endoscopy.

[13]  Yusuke Nakamura,et al.  Genome-wide gene expression profile analysis of esophageal squamous cell carcinomas. , 2006, International journal of oncology.

[14]  Yan Xu,et al.  Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis , 2006, Oncogene.

[15]  T. Sørlie,et al.  Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms , 2006, BMC Genomics.

[16]  Maurice P H M Jansen,et al.  Molecular profiling of platinum resistant ovarian cancer , 2006, International journal of cancer.

[17]  J. Ajani,et al.  Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Carl Barrett,et al.  Prediction of Lymph Node Metastasis in Patients with Endometrioid Endometrial Cancer Using Expression Microarray , 2006, Clinical Cancer Research.

[19]  F. Izzo,et al.  Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Wheatley.  Arginine deprivation and metabolomics: important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells. , 2005, Seminars in cancer biology.

[22]  C. Lightdale,et al.  Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  James Lyons-Weiler,et al.  Prediction of Lymph Node Metastasis by Analysis of Gene Expression Profiles in Primary Lung Adenocarcinomas , 2005, Clinical Cancer Research.

[24]  C. Buskens,et al.  Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction , 2005, Virchows Archiv.

[25]  T. Yeatman,et al.  Dedifferentiation Precedes Invasion in the Progression from Barrett's Metaplasia to Esophageal Adenocarcinoma , 2005, Clinical Cancer Research.

[26]  Stefan Michiels,et al.  Prediction of cancer outcome with microarrays: a multiple random validation strategy , 2005, The Lancet.

[27]  Philip Lijnzaad,et al.  An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas , 2005, Nature Genetics.

[28]  D. Ransohoff.  Bias as a threat to the validity of cancer molecular-marker research , 2005, Nature reviews. Cancer.

[29]  H. Welch,et al.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.

[30]  Wolfgang Huber,et al.  A Compendium to Ensure Computational Reproducibility in High-Dimensional Classification Tasks , 2004, Statistical applications in genetics and molecular biology.

[31]  W. Souba,et al.  Arginine transport in catabolic disease states. , 2004, The Journal of nutrition.

[32]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[33]  James J. Chen,et al.  Analysis of variance components in gene expression data , 2004, Bioinform..

[34]  M. Tada,et al.  Gene-Expression Profile Changes Correlated with Tumor Progression and Lymph Node Metastasis in Esophageal Cancer , 2004, Clinical Cancer Research.

[35]  F. Izzo,et al.  Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  F. Bertucci,et al.  Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters , 2004, Oncogene.

[37]  S. Curley,et al.  Incidence and distribution of argininosuccinate synthetase deficiency in human cancers , 2004, Cancer.

[38]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Mariette,et al.  Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease , 2003, Cancer.

[40]  Paul Fockens,et al.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. , 2002, The New England journal of medicine.

[41]  Martin Vingron,et al.  Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.

[42]  Jing Yin,et al.  Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. , 2002, Cancer research.

[43]  M. Bennett,et al.  The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction , 2002, British Journal of Cancer.

[44]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[45]  L. Mortelmans,et al.  The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. , 2000, The Journal of thoracic and cardiovascular surgery.

[46]  P. Dupont,et al.  Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  L J Schouten,et al.  Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. , 2000, International journal of epidemiology.

[48]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[49]  G. Urso,et al.  Role of positron emission tomography in staging esophageal cancer. , 1997, The Annals of thoracic surgery.

[50]  A. Lavoinne,et al.  Hypoosmolarity and glutamine increased the β‐actin gene transcription in isolated rat hepatocytes , 1996, FEBS letters.